EXPRESSION OF PLATELET-DERIVED GROWTH-FACTOR B-CHAIN AND THE PLATELET-DERIVED GROWTH-FACTOR RECEPTOR-BETA SUBUNIT IN HUMAN BREAST-TISSUE AND BREAST-CARCINOMA
Md. Coltrera et al., EXPRESSION OF PLATELET-DERIVED GROWTH-FACTOR B-CHAIN AND THE PLATELET-DERIVED GROWTH-FACTOR RECEPTOR-BETA SUBUNIT IN HUMAN BREAST-TISSUE AND BREAST-CARCINOMA, Cancer research, 55(12), 1995, pp. 2703-2708
Breast carcinomas are known to express platelet-derived growth factor
(PDGF), a known connective tissue mitogen. In order to further evaluat
e the potential role of PDGF in these epithelial tumors, expression of
the PDGF B chain (PDGF-B) and the PDGF receptor beta subunit (PDGFR)
was analyzed by immunocytochemistry and in situ hybridization in 49 be
nign and malignant breast tissues. PDGF-B expression was analyzed with
respect to the expression of the proliferating cell nuclear antigen,
as well as tumor grade, p53 overexpression, estrogen receptor, progest
erone receptor, and c-erbB-2 expression. Expression of PDGF-B protein
and mRNA was restricted to the breast epithelium and tumor cells excep
t for scattered tissue macrophages. A. strong correlation was found be
tween increasing proliferating cell nuclear antigen indices and PDGF-B
expression in both nonmalignant (P = 0.01) and malignant (P = 0.02) b
reast specimens. Decreased PDGF-B expression was found in postmenopaus
al atrophic breast tissue compared with normal breast tissue (P = 0.04
). Within the subgroup of malignant tumors, no correlations were found
between PDGF-B expression and tumor grade or p53 overexpression. In 1
6 of the malignant tumors evaluated for estrogen/progesterone receptor
status and c-erbB-2 overexpression, no correlations with PDGF-B expre
ssion were found. Membranous PDGFR immunostaining was present within t
he fibroblastic cell population in all of the tissues examined but not
in the nonmalignant breast epithelium. Six malignant specimens had de
tectable cytoplasmic expression of PDGFR. There was no correlation bet
ween this PDGPR expression and proliferating cell nuclear antigen indi
ces, but a correlation was noted between increasing estrogen receptor
expression and PDGFR cytoplasmic expression (P = 0.04). The results su
pport a paracrine role for PDGF-B in malignant and benign breast epith
elial cell proliferation.